Moderna (MRNA) PT Raised to $30 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $64.46 +1.80%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Moderna (NASDAQ: MRNA) to $30.00 (from $29.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Adani Green Energy (ADANIGR:IN) PT Lowered to INR980 at Bernstein SocGen Group
- Regis Resources Ltd. (RRL:AU) (RGRNF) PT Lowered to AUD7.40 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
